Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Monopar Therapeutics Inc. (MNPR) position

Not anymore: Ken Griffin fully exited MNPR in Q2 2021. The position peaked at an amount we cannot price in Q1 2021.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
12K
Quarter-end price
No quarter-end price available

Average buy price is hidden here: this position was already held before our 13F history begins, so the opening cost is unknown and any average would understate it.

MNPR price vs Griffin's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q2 2021 Exited −12K −100.0% 0 Aug 16, 2021
Q1 2021 First covered 12K May 21, 2021
Data through Q2 2021 · filed Aug 16, 2021
2 grouped rows from 2 quarters

More Griffin positions

Common questions

Does Ken Griffin own MNPR?

Not currently. Ken Griffin fully exited MNPR in Q2 2021, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy MNPR?

Ken Griffin held MNPR since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell MNPR?

Yes. Ken Griffin reduced and then fully exited MNPR by Q2 2021; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of MNPR does Ken Griffin own?

None as of the latest filing: Ken Griffin has exited MNPR. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for MNPR?

Ken Griffin began building the MNPR position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.